Immucell Corporation Net Income per Employee (ICCC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immucell Corporation  (NASDAQ: ICCC)
 

Immucell Net Income per Employee

ICCC's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 265.56% in the second quarter 2026, year on year to cumulative value of $1 million, and with 73 employees, Immucell's income per employee grew on trailing twelve month basis to $ 10,786. The income per employee at Immucell' was above the company average.
The Healthcare sector has seen employees of 2 other companies achieving higher income per employee. While Immucell's total ranking has deteriorated compared to the previous quarter from 2460 to 2485.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ICCC Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change 265.56 % 34.18 % - - -
Net Income per Employee (TTM) $ 10,786 -7,471 -14,247 31,831 24,133
ICCC's Total Ranking # 2485 # 2460 # 2435 # 1113 # 1350
Seq. Net Income Change -5.51 % - - - -65.32 %

ICCC Company Profile >> Back to ICCC Efficiency Comparisons >> Compare ICCC Net Income per Employee to its Competitors

ICCC Net Income per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 3
Healthcare Sector # 226
Overall Market # 2485

Net Income per Employee Statistics
High Average Low
$ 31,831 $ -14,063 $ -86,337
(Sep 30 2025)   (Sep 30 2023)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Infusystem Holdings Inc  18,061.31 $ 8.543  Million 473 
Pacira Biosciences inc   17,657.42 $ 14.638  Million 829 
Chemed Corporation  17,392.51 $ 274.993  Million 15,811 
Henry Schein Inc   17,040.00 $ 426.000  Million 25,000 
Nrc Health  16,350.14 $ 5.837  Million 357 
Concentra Group Holdings Parent Inc   15,815.69 $ 205.604  Million 13,000 
Brightspring Health Services Inc   15,548.09 $ 365.380  Million 23,500 
Universal Health Services Inc   15,273.00 $ 1,550.210  Million 101,500 
Davita Inc   15,250.49 $ 1,189.538  Million 78,000 
Ufp Technologies Inc   14,918.49 $ 72.295  Million 4,846 
Conmed Corporation  14,486.41 $ 56.497  Million 3,900 
Integer Holdings Corporation  11,672.45 $ 128.397  Million 11,000 
Immucell Corporation  10,785.93 $ 0.787  Million 73 
Vaso Corporation  8,858.16 $ 2.498  Million 282 
Ensign Group Inc  8,239.89 $ 379.035  Million 46,000 
Atricure Inc   7,816.30 $ 10.552  Million 1,350 
Mimedx Group Inc   7,719.06 $ 6.237  Million 808 
U S Physical Therapy Inc  6,837.26 $ 49.871  Million 7,294 
Ardent Health Inc   6,692.30 $ 168.646  Million 25,200 
Pacs Group Inc   5,671.31 $ 269.132  Million 47,455 
Surgery Partners Inc   5,460.00 $ 81.900  Million 15,000 


Date modified: 2026-09-03T11:51:49+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.